Nuzenio

Applied Biologics Receives

Applied Biologics Receives news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Applied Biologics Gains IRB Approval for Phase 3 BIOxHEAL Trial in Diabetic Foot Ulcers - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 21:15:33 GMTApplied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial - Yahoo Finance SingaporeYahoo Finance Singapore · Wed, 05 Aug 2026 11:21:00 GMTApplied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™ - GlobeNewswireGlobeNewswire · Thu, 30 Jul 2026 07:00:00 GMTApplied Biologics Announces Extension of Longstanding - GlobeNewswireGlobeNewswire · Mon, 27 Jul 2026 14:11:51 GMT

Timeline

Wed, 05 Aug 2026 21:15:33 GMTApplied Biologics Gains IRB Approval for Phase 3 BIOxHEAL Trial in Diabetic Foot Ulcers - BioPharm International
Wed, 05 Aug 2026 11:21:00 GMTApplied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial - Yahoo Finance Singapore
Thu, 30 Jul 2026 07:00:00 GMTApplied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™ - GlobeNewswire
Mon, 27 Jul 2026 14:11:51 GMTApplied Biologics Announces Extension of Longstanding - GlobeNewswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Applied Biologics Receives.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.